Montague International (OTC:MIHL) Stock, Quote.Headers.trade-ideas

Montague International Holding Ltd formerly Hi-Tech Crime Solutions, Inc promotes products and services intended to combat computer security and identity theft.

News

Intraday Update

Markets

Movers

Trading Ideas

ASMIY

CART

CBKW

CMXC

CNMD

CSII

DBOEY

DNPCF

DNPLY

DRADP

DRRX

ENTG

ESSE

HAYN

INNI

IRET

ITRI

KLAC

KMBIF

KNSL

LOOP

MOBL

MRRTY

NGHCN

NYMTP

OMVE

OPYGY

PRTS

RDUS

RSTAY

SWKH

TERP

TMCX

TRCO

TRNO

TSGZF

ZEAL

PFNX

PPPS

MIHL

DFIFF

SHPNF

Stocks That Hit 52-Week Highs On Tuesday

MONTAGUE INTL HLDGS LTD by MONTAGUE INTERNATIONAL HOLDING LTD.

Montague International Holding Ltd

The Food and Drug Administration is taking a significant step to improve consumer access to nutrition information by proposing a front-of-package nutrition label for most packaged foods. This proposal aligns with the agency&#8217;s broader efforts to combat the nation&#8217;s <a href="https://www.benzinga.com/general/health-care">chronic disease crisis.</a>
If implemented, the <a target="_blank" href="https://www.fda.gov/news-events/press-announcements/fda-proposes-requiring-glance-nutrition-information-front-packaged-foods?utm_medium=email&amp;utm_source=govdelivery" rel="noreferrer noopener">label</a> would prominently display key nutritional information, including saturated fat, sodium, and added sugar levels—nutrients known to contribute to chronic diseases when consumed in excess. The initiative aims to provide consumers with a quick, accessible way to evaluate food choices.
The &#8220;Nutrition Info box&#8221; proposed label uses a simple system to categorize foods by their saturated fat, sodium, and added sugar content. Products would be marked with &#8220;Low,&#8221; &#8220;Med,&#8221; or &#8220;High&#8221; labels, providing consumers with a straightforward indicator of how each food fits into a healthy diet.
This new label would complement the FDA&#8217;s existing Nutrition Facts label, which offers more detailed nutrient information.
Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S., affecting approximately 60% of Americans. These diseases majorly contribute to the nation&#8217;s $4.5 trillion healthcare costs.
Research has shown that excessive consumption of certain nutrients, including saturated fat, sodium, and added sugars, plays a key role in developing these conditions.
The FDA conducted extensive research to ensure the new label meets consumer needs, including a 2023 study involving nearly 10,000 U.S. adults.
The study tested various FOP label formats and found that a black-and-white Nutrition Info box with percentage-based daily values was the most effective way to help consumers assess a product&#8217;s healthfulness.
This proposal is part of the White House National Strategy on Hunger, Nutrition, and Health, which aims to reduce diet-related diseases by 2030.
If finalized, the rule would require food manufacturers to implement the new Nutrition Info box within three years for businesses with annual food sales of $10 million or more and within four years for smaller businesses.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/01/42981814/apple-and-nvidia-supplier-taiwan-semiconductor-leads-semiconductor-market-with-64-share" target="_blank" rel="noreferrer noopener">Apple And Nvidia Supplier Taiwan Semiconductor Leads Semiconductor Market with 64% Share</a></li>
</ul>
Photo: Shutterstock

Health Care

General

FDA Proposes Front-Of-Package Label To Improve Nutrition Transparency

Market price action continues to tick up in volatility while still holding a wide range. For this reason, when I trade I&#8217;m choosing option chains that hold a fair bit of premium and choosing a stock that shows reflexive buying when prices dip into monthly support lines. One in particular has caught my eye.
Today, we'll consider what this stock does from a purely technical perspective while we collect revenue from it through another short iron condor. This is typically called an options income generation spread.&nbsp;
Let me show you.
When we position with short iron condors, we attempt to collect time decay while a chart bases or settles before heading in a new or continued direction. As always, we assume that we don't know the direction but are able to estimate the magnitude of the move using the ATR (average true range &#8211; measured on the weekly chart, this time) and the implied moves that the market makers have priced into the move over the months ahead.&nbsp;
The short iron condor consists of two spreads – a short call spread and a short put spread that define a range of motion that we estimate the price action will not exceed:
<ul>
<li>Sell to open 1 PSTG 21 Feb 70 calls </li>
<li>Buy to open 1 PSTG 21 Feb 75 calls </li>
<li>Sell to open 1 PSTG 21 Feb 55 puts </li>
<li>Buy to open 1 PSTG 21 Feb 50 puts </li>
</ul>
At this writing the credit received is $1.09 and this credit is also the maximum profit we could collect overall. With this kind of position, we collect a premium and as this premium erodes, we collect revenue from the position.&nbsp;
Our maximum risk is calculated in the following way: the distance between strikes (here they are both the same at $5), so $5.00, minus the amount of the credit we collect, which is $1.09 = $3.91&nbsp;
Why take a trade where the risk is often more than twice the size of the reward? The answer is this – the probability of the short iron condor with strikes far out of the money (meaning far away from the price of the stock currently) potentially returning gains is often as much as 6 times more likely than the long iron condor in this specific example.&nbsp;
Trading on the side of probabilities, rather than the possibility of outsized gains, is the way most traders who sell options as their primary revenue generation lean on the law of large numbers – what happens over a long period of time – converging to net gains, generally speaking.&nbsp;
The price for PSTG is currently range bound with resistance near $70 and support near $55, which is how I picked the strike prices for the trade.&nbsp;
The strategy result provides three choices to exit the trade:
<ol>
<li>To buy back the iron condor once it gets to an acceptable profit margin for you. I customarily look for 30%-60% profit for these kinds of trades in the current environment of volatility. </li>
<li>To buy back the iron condor once it hits a loss threshold as determined by personal risk – this will happen with extreme movement. I customarily look at about 50% though depending on my size </li>
<li>To buy back the spreads into the week before expiration, if all is going well and you have decided to hold the trade into closer to the end of expiration (I have had many a trade go sideways taking it down to the wire and not capturing gains, so I do not advise this). </li>
</ol>
<a href="https://benzinga.zoom.us/webinar/register/WN_OJ2FBspHSJSSVNlW8zGapw/?utm_source=WebRD-0114&amp;el=ResearchDaily&amp;he={{email}}">Starting Soon: Profitable Trading Strategies Webinar at 6 PM ET Tonight!</a> Join Ryan Faloona and Anne-Marie Baiynd tonight (Tuesday) at 6 PM ET to uncover momentum plays, opportunities during earnings season, and advanced trading techniques. Gain the tools and insights you need to succeed. <a href="https://benzinga.zoom.us/webinar/register/WN_OJ2FBspHSJSSVNlW8zGapw/?utm_source=WebRD-0114&amp;el=ResearchDaily&amp;he={{email}}">Click here to reserve your spot and get the webinar link</a>
Courtesy of Arm Holdings Plc

Opinion

The Best Income Trade for Tomorrow

Dividends

LKFN

Lakeland Financial Corporation Announced A Quarterly Cash Dividend For The First Quarter of 2025 Of $0.50 Per Share, Payable February 5, 2025, To Shareholders Of Record As Of January 25, 2025. The Quarterly Dividend Represents A 4% Increase Over The Quarterly Dividend Rate Of $0.48 Per Share Paid In 2024.

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) Albert Bourla, Chairman and CEO, said, &#8220;I think we did significant transformative changes in Pfizer.&#8221;
Pfizer&#8217;s CEO stated that the company revamped its commercial strategy, brought in new leadership, and exceeded market share expectations. On the cost side, Pfizer achieved $4 billion in savings and announced an additional $1.5 billion in margin improvements.
In R&amp;D, leadership <a target="_blank" href="https://investors.pfizer.com/files/doc_events/2025/Jan/13/PFE-USQ_Transcript_2025-01-13.pdf" rel="noreferrer noopener">changed</a> for the first time in 15 years, with Mikael Dolsten stepping down, and the team underwent a restructuring. Bourla also highlighted returns to shareholders, including over $7 billion in dividends and $4.5 billion toward debt repayment in the first nine months.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42873977/safety-labels-updated-for-pfizer-and-gsks-rsv-vaccines-fda-adds-warning-for-rare-neurological-disorder" rel="noreferrer noopener">Pfizer And GSK&#8217;s RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder</a>
Looking at the period from 2025 to 2030, Pfizer is facing a significant loss of exclusivity (LOE) wave that will reduce revenues by about $17-18 billion between 2026 and 2028.
Bourla said the products acquired are projected to bring in $20 billion in revenue by 2030, which should offset those losses and provide some growth.
Additionally, the company is counting on revenues from products already launched and others in the pipeline. This is where the gap lies between Pfizer&#8217;s outlook and market expectations.
While new product launches in 2023 were underwhelming, Pfizer made significant progress in 2024, which makes the company optimistic about future performance.
When asked about the visibility into the business, Albert Bourla added that the main difference between 2024 and 2025 is the stabilization of the COVID business.
In 2024, guidance reflected significant uncertainty, partly due to miscalculations in COVID-19 revenue, the transition of Paxlovid to a commercial model, and contract renegotiations with Europe. As a result, Pfizer was cautious when setting expectations.
For 2024, the company reconfirmed guidance in December. For 2025, projections are similarly strong, with COVID revenues expected <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42530634/pfizer-does-not-anticipate-material-changes-to-us-vaccine-policy-from-the-incoming-administration-in-2025" rel="noreferrer noopener">to remain stable</a>.
Vaccination rates are low but consistent, and Pfizer anticipates achieving similar results in 2025 as in 2024.
For Paxlovid, demand closely tracks COVID waves, which have followed a predictable pattern over the last three years—two waves annually. Overall, the company foresees stability in our COVID business moving forward.
Price Action: PFE stock is down 1.49% at $26.40 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42978906/regeneron-pipeline-aims-to-address-220-billion-therapeutic-opportunities-by-2030" target="_blank" rel="noreferrer noopener">Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030</a></li>
</ul>
Photo via Shutterstock

Biotech

Large Cap

Guidance

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges

BOWN

Bowen Acquisition Corp Resumes Trade

Seaport analyst Jeff Cantwell upgraded Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) to Buy from <a target="_blank" href="https://www.benzinga.com/quote/V/analyst-ratings" rel="noreferrer noopener">Neutral with a price target of $359</a>.
The analyst raised forecasts for the company, which are above consensus for both 2025 and 2026.
Also, for this year, the analyst prefers Visa on a relative basis over Mastercard, primarily due to Visa&#8217;s more significant U.S. exposure.
The analyst projects stronger service/data processing revenue for 2025 and 2026, driven by a firming U.S. economy in the second half of this year.
Cantwell also boosted the Other Revenue estimates, expecting higher demand for value-added services (VAS) from Visa&#8217;s clients.
The analyst anticipates double-digit revenue growth for Visa in 2025 and 2026, with 13% EPS growth in both years.
The upcoming Investor Day in February is also seen as a positive catalyst for investors, adds the analyst.
Overall, in a macro environment expected to be somewhat turbulent in 2025, the analyst views Visa as a steady earnings compounder with upside potential compared to consensus estimates.
Investors can gain exposure to the stock via iShares U.S. Financial Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>) and SPDR Select Sector Fund &#8211; Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>).
Price Target: V shares are up 0.87% at $309.58 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42971921/mastercard-vs-visa-bearish-trends-bullish-hopes" target="_blank" rel="noreferrer noopener">Mastercard Vs. Visa: Technical Challenges Ahead Of Earnings Showdown</a></li>
</ul>
Photo by In Green via Shutterstock.

Analyst Color

Equities

Upgrades

Price Target

Analyst Ratings

iShares Trust Dow Jones US Financial Services Index Fund

This Analyst Prefers Visa Over Mastercard In 2025 - Here's Why

International Data Corp cites preliminary data showing that <a target="_blank" href="https://www.benzinga.com/topic/smartphones" rel="noreferrer noopener">global smartphone shipments</a> increased 2.4% to 331.7 million units in the fourth quarter of 2024.
This marks the sixth consecutive quarter of shipment growth, and after two years of decline, the year closed with 6.4% growth and 1.24 billion shipments.
Nabila Popal <a target="_blank" href="https://www.idc.com/getdoc.jsp?containerId=prUS53072325" rel="noreferrer noopener">of IDC</a> noted that vendors successfully adjusted their strategies to drive growth by focusing on promotions, launching devices in multiple price segments, offering interest-free financing plans, and aggressively trading in devices, fueling premiumization and boosting low-end devices, especially in China and emerging markets.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42958251/on-semi-sees-utilization-cuts-as-ev-demand-softens-analyst-warns" rel="noreferrer noopener">ON Semi Sees Utilization Cuts As EV Demand Softens, Analyst Warns</a>
Popal expressed optimism about continued growth in 2025 while flagging the threat of tariffs from the Donald Trump administration, which has triggered uncertainty in the industry.
IDC expects the market to continue growing at a slower pace in 2025 as refresh cycles continue to grow and pent-up demand is fulfilled.
While Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) maintained the top two positions in the fourth quarter and for the year, both companies witnessed year-on-year declines and lost market share to the Chinese vendors this year who drove the overall market by focusing on affordable devices, rapid expansion, and development in China.
Outside of Apple and Samsung, Xiaomi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACF#OTC">XIACF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>) came in third for the quarter and the year, with the highest year-on-year growth rate among the top five players. Transsion placed fourth but tied with Vivo for the quarter and Oppo for the year.
Francisco Jeronimo called out Xiaomi, Oppo, Vivo, Honor, Huawei, Lenovo, Realme, Transsion, TCL, and ZTE for their remarkable fourth quarter.
They shipped the highest combined volume ever in a quarter, representing 56% of the global smartphone shipments.
While their core markets remain China and Asia, Jeronimo noted that these brands are expanding their footprint in Europe and Africa thanks to their low-end and mid-range devices. Huawei stands apart, with most of its shipments in the high-end and premium segments.
Also this week, Counterpoint <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/25/01/42951487/apples-iphone-market-share-declines-in-china-huawei-and-xiaomi-gain-momentum-in-2024-counterpoint" rel="noreferrer noopener">pointed out how</a> iPhones, devoid of their Apple Intelligence features, failed to gain traction in China, making way for the domestic players in 2024.
As per Counterpoint, global smartphone sales grew 4% in 2024, led by Europe, China, and Latin America.
Counterpoint expects AI-capable smartphones to become a norm for mid-range devices. By 2028, Counterpoint expects 90% of smartphones priced above $250 to be Generative AI-capable.
Apple stock surged 28% in last 12 months. Investors can gain exposure to the stock through iShares Global Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IXN#NYSE">IXN</a>) and Fidelity MSCI Information Technology Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>).
Price Action: AAPL stock traded higher by 0.12% at $234.67 at the last check on Tuesday.
Also Read:
<ul>
<li><a href="http://Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum" target="_blank" rel="noreferrer noopener">Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum</a></li>
</ul>
Photo courtesy: Apple

Tech

Media

AAPL

FTEC

iShares Trust S&P Global Information Technology Sector Index Fund

SSNLF

XIACF

XIACY

Apple Sees Market Share Decline in 2024 as Chinese Smartphone Brands Surge Globally: IDC

Bowen Acquisition Corp Shares Halted On A Circuit Breaker To The Upside, Stock Now Up 16.2%

Bowen Acquisition Corp Shares Resume Trade

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has gained 16% over the past week, fueled by growing confidence in Ripple's legal battle and the anticipated <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42878368/xrp-etf-very-soon-likely-next-after-bitcoin-and-ethereum-ripple-president-says">launch of XRP ETFs</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.67</td>
<td>$153.7 billion</td>
<td>+9.8%&nbsp;</td>
<td>&nbsp;+16.2%</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$96,573.27</td>
<td>$1.9 trillion</td>
<td>+5.4%&nbsp;</td>
<td>-0.5%&nbsp;</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,217.65</td>
<td>$387.6 billion</td>
<td>+7.4%&nbsp;</td>
<td>-6.2%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto chart analyst Ali Martinez sees XRP as one of the most bullish setups after a successful retest of the breakout zone.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> has one of the most bullish setups in crypto right now after the recent retest of the breakout zone! <a href="https://t.co/YPjgv2MPzF">pic.twitter.com/YPjgv2MPzF</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1879123409109754198?ref_src=twsrc%5Etfw">January 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another trader, DonAlt, believes XRP has the potential to temporarily surpass Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) and possibly even Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) under extreme conditions. 
While describing XRP as a &#8220;perfect scam&#8221; aligned with U.S. political dynamics, he <a href="https://x.com/CryptoDonAlt/status/1879204384669839605">acknowledges</a> its significant role in the current crypto market.
Crypto Rand highlights XRP's resilience, noting that it continues to lead market reversals.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> keeps delivering and leading the reversal &#x1f440; <a href="https://t.co/wHI0Z9pJNt">pic.twitter.com/wHI0Z9pJNt</a>
&mdash; Crypto Rand (@crypto_rand) <a href="https://twitter.com/crypto_rand/status/1879219708941291579?ref_src=twsrc%5Etfw">January 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: JPMorgan predicts Ripple&#8217;s XRP ETFs could draw nearly $8 billion in investments, as 2025 may see the resolution of Ripple's legal battle with the SEC.
According to Nancy Pelosi Stock Tracker, Representative Guy Reschenthaler (R-PA) disclosed a $15,000 XRP purchase in November 2024—a positive <a href="https://x.com/PelosiTracker_/status/1879171266663645305">signal</a> for the Ripple community.
The SEC's decision to file its opening brief in the appeal against Judge Torres&#8217; ruling in the Ripple case is being eagerly <a href="https://watcher.guru/news/xrp-on-edge-sec-appeal-looms-as-ripple-countdown-hits-critical-stage">awaited</a> by the market.
Community News: Ripple President Monica Long recently remarked on <a href="https://x.com/MonicaLongSF/status/1878993104877011051">X</a> that many banks are already adopting crypto, with more to follow as regulations improve. 
This could position XRP as a key player in driving mainstream adoption.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42900509/social-media-sentiment-report-shows-only-one-out-of-bitcoin-xrp-dogecoin-is-bullish">Social Media Sentiment Report Shows Only One Out Of Bitcoin, XRP, Dogecoin Is Bullish</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Up 16% In 7 Days: Could It Temporarily Flip Ethereum Or Even Bitcoin?

Contracts

BZAI

Blaize Holdings Announced They Have Entered Into A Joint Technology Commercial Agreement With VSBLTY Groupe Technologies Corp For The Development And Deployment Of Complete Ai-Enabled Safety And Security Solutions

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 200 points on Tuesday.
The Dow traded up 0.50% to 42,509.79 while the NASDAQ rose 0.25% to 19,135.49. The S&amp;P 500 also rose, gaining, 0.33% to 5,855.26.
Check This Out: <a href="https://www.benzinga.com/25/01/42969701/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month-2">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month</a>
Leading and Lagging Sectors Utilities shares rose by 1.1% on Tuesday.
In trading on Tuesday, health care shares tumbled by 1.6%.
Top Headline
U.S. producer prices rose 0.2% month-over-month in December compared to 0.4% in November, and versus market estimates of 0.3%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Firefly Neuroscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) shares shot up 88% to $3.58 after the company announced the advancement of research to assess a patient's brain age using its BNA technology platform.</li>
<li>Shares of Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>)got a boost, surging 96% to $2.20. Nature&#8217;s Miracle Holding announced that it entered into a Securities Purchase Agreement with a single institutional investor on Jan. 10, 2025.</li>
<li>H&amp;E Equipment Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) shares were also up, gaining 106% to $90.38 after United Rentals announced it will acquire the company for $92 per share in cash.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares dropped 52% to $55.91 after the company announced a $3.19 million registered direct offering.</li>
<li>Shares of Signet Jewelers Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) were down 24% to $55.91 after the company reported a drop in total same store sales for the holiday season and lowered its fourth-quarter guidance.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) was down, falling 37% to $0.1417 after the company announced a 1-for-50 reverse stock split.</li>
</ul>
Commodities In commodity news, oil traded down 1.3% to $77.80 while gold traded up 0.2% at $2,683.80.
Silver traded up 0.4% to $30.425 on Tuesday, while copper rose 0.3% to $4.3375.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.08%, Germany's DAX 40 gained 0.69% and France's CAC 40 gained 0.20%. Spain's IBEX 35 Index gained 0.55%, while London's FTSE 100 slipped 0.28%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 1.83%, China's Shanghai Composite Index jumping 2.54%, Hong Kong's Hang Seng Index gaining 1.83% and India's BSE Sensex rising 0.22%.
Economics
<ul>
<li>U.S. producer prices rose 0.2% month-over-month in December compared to 0.4% in November, and versus market estimates of 0.3%.</li>
<li>The RealClearMarkets/TIPP Economic Optimism Index declined to 51.9 in January versus a reading of 54 in the previous month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42971698/wall-streets-most-accurate-analysts-spotlight-on-3-tech-and-telecom-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Eurozone

Commodities

AIFF

HEES

MBIO

NMHI

PHIO

Dow Gains Over 200 Points; Signet Jewelers Shares Plunge

Citigroup analyst Ashwin Shirvaikar maintains SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Buy and raises the price target from $12.5 to $18.

SOFI

Citigroup Maintains Buy on SoFi Techs, Raises Price Target to $18

Lantheus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Lantheus Holdings, revealing an average target of $121.75, a high estimate of $143.00, and a low estimate of $112.00. Observing a downward trend, the current average is 1.81% lower than the prior average price target of $124.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736881258_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Lantheus Holdings among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Turkaly</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$112.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Paul Choi</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$143.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>David Turkaly</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$112.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Lantheus Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Lantheus Holdings compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Lantheus Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Lantheus Holdings's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LNTH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lantheus Holdings analyst ratings.</a>
<h2>About Lantheus Holdings</h2>
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
<h3>Lantheus Holdings: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3 months period, Lantheus Holdings showcased positive performance, achieving a revenue growth rate of 18.37% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Lantheus Holdings's net margin is impressive, surpassing industry averages. With a net margin of 34.61%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Lantheus Holdings's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.88% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Lantheus Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of 6.57%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.52.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LNTH

What 4 Analyst Ratings Have To Say About Lantheus Holdings

In the latest quarter, 21 analysts provided ratings for Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">15</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">10</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $338.57, a high estimate of $375.00, and a low estimate of $292.00. This upward trend is evident, with the current average reflecting a 6.39% increase from the previous average price target of $318.24.
<img src="https://www.benzinga.com/files/images/story/2025/1736881251_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Visa among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Schmidt</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$354.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>Donald Fandetti</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$360.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$375.00</td>
<td>$321.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$371.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$375.00</td>
<td>$339.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$360.00</td>
<td>$335.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$347.00</td>
<td>$319.00</td>
</tr>
<tr>
<td>Dan Dolev</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$292.00</td>
<td>$279.00</td>
</tr>
<tr>
<td>Paul Golding</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$335.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Bryan Bergin</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$325.00</td>
<td>$318.00</td>
</tr>
<tr>
<td>Andrew Schmidt</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$326.00</td>
<td>$319.00</td>
</tr>
<tr>
<td>Trevor Williams</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$330.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$322.00</td>
<td>$311.00</td>
</tr>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$321.00</td>
<td>$318.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$320.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$339.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$326.00</td>
<td>$322.00</td>
</tr>
<tr>
<td>Bryan Keane</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$340.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>David Koning</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$340.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$322.00</td>
<td>$319.00</td>
</tr>
<tr>
<td>David Koning</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$330.00</td>
<td>$320.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Visa. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Visa compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Visa's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Visa's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/V/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Visa analyst ratings.</a>
<h2>All You Need to Know About Visa</h2>
Visa is the largest payment processor in the world. In fiscal 2023, it processed almost $15 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
<h3>Key Indicators: Visa's Financial Health</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Visa showcased positive performance, achieving a revenue growth rate of 11.71% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Visa's net margin excels beyond industry benchmarks, reaching 55.3%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Visa's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 13.92% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Visa's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 5.73%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.55, Visa adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Visa Stock: A Deep Dive Into Analyst Perspectives (21 Ratings)

5 analysts have shared their evaluations of Plymouth Industrial REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLYM#NYSE">PLYM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Plymouth Industrial REIT, presenting an average target of $23.0, a high estimate of $27.00, and a low estimate of $19.00. Experiencing a 8.0% decline, the current average is now lower than the previous average price target of $25.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736881244_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Plymouth Industrial REIT by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mitch Germain</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$27.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Anthony Hau</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$22.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Plymouth Industrial REIT. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Plymouth Industrial REIT compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Plymouth Industrial REIT's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Plymouth Industrial REIT's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PLYM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Plymouth Industrial REIT analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Plymouth Industrial REIT Better</h2>
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income primarily from the rental revenue through its properties.
<h3>A Deep Dive into Plymouth Industrial REIT's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Plymouth Industrial REIT's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 4.23%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: Plymouth Industrial REIT's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -30.25%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.44%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Plymouth Industrial REIT's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.08%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.89, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PLYM

Assessing Plymouth Industrial REIT: Insights From 5 Financial Analysts

Investors with a lot of money to spend have taken a bullish stance on GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GEV, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 57 uncommon options trades for GE Vernova.
This isn't normal.
The overall sentiment of these big-money traders is split between 42% bullish and 36%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $476,015, and 48 are calls, for a total amount of $3,536,323.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $440.0 for GE Vernova over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for GE Vernova's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GE Vernova's whale activity within a strike price range from $250.0 to $440.0 in the last 30 days. 
<h3>GE Vernova 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736881229_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$31.3</td>
<td>$29.8</td>
<td>$31.29</td>
<td>$410.00</td>
<td>$406.8K</td>
<td align="right">83</td>
<td align="right">131</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$35.5</td>
<td>$33.6</td>
<td>$34.55</td>
<td>$400.00</td>
<td>$345.4K</td>
<td align="right">307</td>
<td align="right">332</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$34.8</td>
<td>$33.6</td>
<td>$34.78</td>
<td>$400.00</td>
<td>$208.7K</td>
<td align="right">307</td>
<td align="right">232</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$63.1</td>
<td>$60.5</td>
<td>$61.25</td>
<td>$440.00</td>
<td>$208.3K</td>
<td align="right">5</td>
<td align="right">34</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$36.1</td>
<td>$34.8</td>
<td>$34.8</td>
<td>$400.00</td>
<td>$139.2K</td>
<td align="right">307</td>
<td align="right">132</td>
</tr>
</tbody>
</table>

<h3>About GE Vernova</h3>
GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.
<h3>Where Is GE Vernova Standing Right Now?</h3>
<ul>
<li>With a volume of 1,690,627, the price of GEV is up 5.11% at $385.56. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>Expert Opinions on GE Vernova</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $394.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for GE Vernova, targeting a price of $374. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on GE Vernova with a target price of $415. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for GE Vernova, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

GE Vernova Unusual Options Activity For January 14

In the latest quarter, 14 analysts provided ratings for Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $219.07, a high estimate of $267.00, and a low estimate of $183.00. This current average has increased by 6.31% from the previous average price target of $206.07. 
<img src="https://www.benzinga.com/files/images/story/2025/1736881227_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Allstate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$187.00</td>
<td>$186.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$243.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$183.00</td>
<td>$187.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$244.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$230.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$267.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$228.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$186.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$187.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$233.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$214.00</td>
<td>$205.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Allstate. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Allstate compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Allstate's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Allstate's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Allstate analyst ratings.</a>
<h2>Get to Know Allstate Better</h2>
Allstate is one of the largest us property-casualty insurers in the us. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
<h3>Financial Insights: Allstate</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Allstate showcased positive performance, achieving a revenue growth rate of 14.69% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Allstate's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 6.98%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Allstate's ROE excels beyond industry benchmarks, reaching 6.55%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Allstate's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.05%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 0.43, Allstate faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Allstate: Insights From 14 Analyst Reviews

Whales with a lot of money to spend have taken a noticeably bullish stance on Wolfspeed.
Looking at options history for Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 38% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $614,167 and 4, calls, for a total amount of $114,174.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4.0 and $20.0 for Wolfspeed, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Wolfspeed options trades today is 1777.33 with a total volume of 24,017.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Wolfspeed's big money trades within a strike price range of $4.0 to $20.0 over the last 30 days.
<h3>Wolfspeed Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736881224_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.6</td>
<td>$8.00</td>
<td>$258.1K</td>
<td>2.5K</td>
<td>717</td>
</tr>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.5</td>
<td>$0.48</td>
<td>$0.49</td>
<td>$4.00</td>
<td>$85.4K</td>
<td>7.8K</td>
<td>5.7K</td>
</tr>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.48</td>
<td>$0.47</td>
<td>$0.47</td>
<td>$4.00</td>
<td>$80.1K</td>
<td>7.8K</td>
<td>2.0K</td>
</tr>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$0.49</td>
<td>$0.31</td>
<td>$0.47</td>
<td>$4.00</td>
<td>$36.3K</td>
<td>7.8K</td>
<td>2.8K</td>
</tr>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$1.4</td>
<td>$1.38</td>
<td>$1.38</td>
<td>$4.00</td>
<td>$35.6K</td>
<td>1.7K</td>
<td>378</td>
</tr>
</tbody>
</table>

<h3>About Wolfspeed</h3>
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
Having examined the options trading patterns of Wolfspeed, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Wolfspeed</h3>
<ul>
<li>Currently trading with a volume of 11,836,267, the WOLF's price is down by -1.63%, now at $4.83. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Wolfspeed, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

WOLF

Decoding Wolfspeed's Options Activity: What's the Big Picture?

In the latest quarter, 11 analysts provided ratings for Zebra Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Zebra Technologies, revealing an average target of $406.82, a high estimate of $445.00, and a low estimate of $305.00. This upward trend is apparent, with the current average reflecting a 11.52% increase from the previous average price target of $364.80.
<img src="https://www.benzinga.com/files/images/story/2025/1736881220_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Zebra Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Piyush Avasthy</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$430.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$408.00</td>
<td>$383.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$427.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$400.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$407.00</td>
<td>$347.00</td>
</tr>
<tr>
<td>Joseph Giordano</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$425.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$305.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$383.00</td>
<td>$379.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$445.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$415.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$430.00</td>
<td>$394.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Zebra Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Zebra Technologies compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Zebra Technologies's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Zebra Technologies's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ZBRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Zebra Technologies analyst ratings.</a>
<h2>Get to Know Zebra Technologies Better</h2>
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
<h3>Zebra Technologies: Delving into Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Zebra Technologies's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 31.28%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Zebra Technologies's net margin is impressive, surpassing industry averages. With a net margin of 10.92%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Zebra Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.08%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Zebra Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.8% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.69, caution is advised due to increased financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ZBRA

Analyst Expectations For Zebra Technologies's Future

Montague International

Comments

Montague International

Montague International (MIHL) Forecast

Montague International (OTC:MIHL) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga